Graeme Milligan, PhD, is Gardiner Professor of Biochemistry, and Deputy Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow. His research group focuses on the function, pharmacology, and regulation of GPCRs and their interacting proteins. His experience also includes translating knowledge generated into selection of targets, screening, and identification of small molecule regulators of these proteins and progressing such ligands in drug development programs. Prof. Milligan is the co-founder of both Caldan Therapeutics and of Keltic Pharma Therapeutics.